Dr. Nathan Pennell, medical oncologist and lung cancer expert at
the Cleveland Clinic Foundation, reviews the current evidence and
future directions for use of molecular markers such as EGFR, KRAS,
ERCC-1, EML4-ALK, and others in NSCLC.
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.